Suppr超能文献

大核心缺血性卒中的当前及新兴血管内和神经重症护理管理策略

Current and Emerging Endovascular and Neurocritical Care Management Strategies in Large-Core Ischemic Stroke.

作者信息

Migdady Ibrahim, Johnson-Black Phoebe H, Leslie-Mazwi Thabele, Malhotra Rishi

机构信息

Division of Critical Care Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA.

Department of Neurology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA.

出版信息

J Clin Med. 2023 Oct 20;12(20):6641. doi: 10.3390/jcm12206641.

Abstract

The volume of infarcted tissue in patients with ischemic stroke is consistently associated with increased morbidity and mortality. Initial studies of endovascular thrombectomy for large-vessel occlusion excluded patients with established large-core infarcts, even when large volumes of salvageable brain tissue were present, due to the high risk of hemorrhagic transformation and reperfusion injury. However, recent retrospective and prospective studies have shown improved outcomes with endovascular thrombectomy, and several clinical trials were recently published to evaluate the efficacy of endovascular management of patients presenting with large-core infarcts. With or without thrombectomy, patients with large-core infarcts remain at high risk of in-hospital complications such as hemorrhagic transformation, malignant cerebral edema, seizures, and others. Expert neurocritical care management is necessary to optimize blood pressure control, mitigate secondary brain injury, manage cerebral edema and elevated intracranial pressure, and implement various neuroprotective measures. Herein, we present an overview of the current and emerging evidence pertaining to endovascular treatment for large-core infarcts, recent advances in neurocritical care strategies, and their impact on optimizing patient outcomes.

摘要

缺血性中风患者梗死组织的体积一直与发病率和死亡率的增加相关。最初针对大血管闭塞的血管内血栓切除术研究排除了已形成大梗死核心的患者,即使存在大量可挽救的脑组织,因为出血转化和再灌注损伤的风险很高。然而,最近的回顾性和前瞻性研究表明血管内血栓切除术的预后有所改善,并且最近发表了几项临床试验来评估对存在大梗死核心的患者进行血管内治疗的疗效。无论是否进行血栓切除术,有大梗死核心的患者仍面临院内并发症的高风险,如出血转化、恶性脑水肿、癫痫发作等。专业的神经重症监护管理对于优化血压控制、减轻继发性脑损伤、管理脑水肿和颅内压升高以及实施各种神经保护措施是必要的。在此,我们概述了与大梗死核心的血管内治疗相关的现有和新出现的证据、神经重症监护策略的最新进展及其对优化患者预后的影响。

相似文献

本文引用的文献

4
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation.早期与晚期抗凝治疗房颤相关性脑卒中。
N Engl J Med. 2023 Jun 29;388(26):2411-2421. doi: 10.1056/NEJMoa2303048. Epub 2023 May 24.
8
Trial of Endovascular Thrombectomy for Large Ischemic Strokes.大型缺血性卒中血管内血栓切除术试验
N Engl J Med. 2023 Apr 6;388(14):1259-1271. doi: 10.1056/NEJMoa2214403. Epub 2023 Feb 10.
9
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.大面积梗死急性缺血性卒中血管内治疗试验
N Engl J Med. 2023 Apr 6;388(14):1272-1283. doi: 10.1056/NEJMoa2213379. Epub 2023 Feb 10.
10
Improved Prospects for Thrombectomy in Large Ischemic Stroke.大缺血性卒中血栓切除术的前景改善
N Engl J Med. 2023 Apr 6;388(14):1326-1328. doi: 10.1056/NEJMe2300193. Epub 2023 Feb 10.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验